Team |
Rammohan Devulapally, PhD
Rammohan Devulapally, PhD

Rammohan Devulapally, PhD


Nonviral Delivery

Ram leads non-viral delivery platform development at Life Edit Therapeutics. He has more than ten years of experience in non-viral gene delivery, focusing on developing innovative nonviral delivery platforms for nucleic acid therapeutics.

Before joining Life Edit, Ram led non-viral gene delivery as a Principal Scientist at GenEdit. Previously, Ram led lipid nanoparticle platform development at ReCode Therapeutics. Before this, Ram held research positions at Stanford University and Texas A&M University. 

Ram completed a PhD in Organic Synthesis from National Chung Cheng University, Taiwan, as well as a M.S. in Organic Chemistry and a B.S. in Chemistry from Kakatiya University, India.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.